See also this year's filing and all EDGAR filings for this company.
PDF Report 0001697532_2022_Applied_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001697532')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001697532, Applied Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 88,394,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,498,000 |
| 4 | LiabilitiesCurrent | 26,462,000 |
| 5 | LiabilitiesNoncurrent | 891,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,048,000 |
| 9 | ResearchAndDevelopmentExpense | 62,570,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 34,000 |
| 13 | remainder_ComprehensiveNetIncome | 5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 89,892,000 |
| 1 | Liabilities | 27,353,000 |
| 2 | Expenses | 105,618,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 62,539,000 |
| 5 | NetIncome | -105,584,000 |
| 6 | ComprehensiveNetIncome | -105,581,500 |
| 7 | BaseVar | 111,451,000 |
| 8 | EconomicCapitalRatio | 0.0339 |
Edgar->Model Mapping
Feature Distribution
Change over Time
